Prices of essential medicines in Khyber Pakhtunkhwa have seen a significant rise, sparking serious concern among patients and healthcare professionals. Among the most affected is insulin, a life-saving drug for diabetic patients, whose cost has increased dramatically. The price of an insulin injection device has jumped from Rs2,200 to Rs4,720, more than doubling and placing a heavy burden on those who rely on it for daily treatment.
Medical experts warn that such a sharp increase could have dangerous consequences. Many diabetic patients, particularly those from low-income backgrounds, may struggle to afford regular doses. This could lead to missed treatments, poor blood sugar control, and a higher risk of severe health complications.
In addition to insulin, several other commonly used medicines have also become more expensive. A medication used for acidity and indigestion has risen from Rs530 to Rs620, while the cost of vitamins and nutritional supplements has increased from Rs480 to Rs510. Similarly, the price of a drug for vitamin B deficiency has gone up from Rs500 to Rs600.
The impact extends to patients with other chronic conditions as well. A thyroid medication has seen a steep rise, jumping from Rs85 to Rs290, while a drug used for treating typhoid has increased from Rs805 to Rs930.
According to sources, these revised prices have been officially approved and are already in effect at pharmacies, particularly in Peshawar. Patients and pharmacists alike have expressed concern, noting that rising costs may force people to reduce or skip treatments.
Doctors have cautioned that such trends could lead to worsening health outcomes and increased hospitalisations. They have urged authorities to review the price hikes and introduce relief measures to ensure that essential medicines remain accessible and affordable for all.
Read more: Punjab Issues Alert Over Fake Medicines
